PROSPECTIVE EVALUATION OF HYPOFRACTIONATION PROTON BEAM THERAPY WITH CONCURRENT TREATMENT OF THE PROSTATE AND PELVIC NODES FOR CLINICALLY LOCALIZED, HIGH RISK OR UNFAVORABLE INTERMEDIATE RISK PROSTATE CANCER: